Skip to main content

Get Health Care
About
Giving
Find Faculty
Library
Rush U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Education
Looking to take the next step in your career? Rush University offers a wide range of education and training options, including nationally ranked academic programs.

Find a Program
- Colleges
- Quick Links
Admissions
Student Life
Experience what life is like at Rush University, and discover what our supportive learning community has to offer.

Learn More About Student Life
- About the Rush Experience
- Quick Links
Research
Rush researchers are leading efforts to cure disease and promote health equity — in Chicago and around the world.

Learn More About Research
- About Our Research
- Quick Links

Get Health Care
About
Giving
Find Faculty
Library
Rush U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Search RUSH University

Brandon R. Barton, MD, MS

Breadcrumb

Home
Brandon R. Barton, MD, MS

Home

Associate Professor, Department of Neurological Sciences

Rush Medical College

Associate Professor, Department of Neurological Sciences

Contact Information

Address: 1725 W. Harrison St., Suite 755
Chicago, IL 60612
Phone:
(312) 563-2900
Fax:
(312) 563-2024

Links

Print this Page

Off

MD, Medical College of Wisconsin
MS, in clinical research, Rush University Medical College
Neurology residency, Rush University Medical Center
Movement disorders fellowship, Rush University Medical Center
Brandon Barton, MD, is from Salt Lake City, Utah where he completed his undergraduate work at the University of Utah. He received his medical doctorate at The Medical College of Wisconsin in 2003, after which he joined Rush University to complete his professional training in neurology. He completed his fellowship specialty training in Parkinson’s disease and movement disorders in 2009. He splits his practice between Rush University Medical Center and the nearby Jesse Brown VA Medical Center, where he runs the VA-affiliated Movement Disorders clinic. He sees all types of adult movement disorder patients, with special interests in Veteran’s issues, cognitive/psychiatric features, and difficult diagnostic cases.
Fellow of the American Academy of Neurology, 2019

Movement Disorders Society LEAP Leadership training program, 2015

National Meeting May 2013: American Neurological Association Translational and Clinical Research Course for Clinician Scientists, 2013

National Institute of Neurological Disorders & Stroke (NINDS), Junior Academic Neurologist Scholarship, Career Development Symposium & American Neurological Association (ANA) Junior Faculty Development Course, 2010

Blue Ribbon 2010 International Movement Disorders Society, 2010

National Institutes of Health (NIH) Clinical Trial Methods Course in Neurology, 2010

Veterans Administration Cooperative Studies Program Clinical Trial Design Course, 2010

Travel Scholarship, Movement Disorder Society International Congress, 2009

ANA Residents Symposium Scholarship, 2006

The Arnold P. Gold Foundation Leonard Tow Humanism in Medicine, 2003

Medical College of Wisconsin Alumni Association Scholarship, 2002
US WorldMeds
USWM-SA1-4001
Principal Investigator
A Prospective, Observational Study to Evaluate Changes in Non-Motor Symptoms and Other Clinical Outcome Assessments of Parkinson’s disease Patients Treated with XADAGO (safinamide) Tablets

Adamas Pharmaceuticals
ADS-PAR-AM201
Sub Investigator
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia

VA CDA
JBVA
Co-Investigator
Characterizing cognitive function in Veterans with Parkinson's disease

EMD Serono, Inc.
27919/SETTLE
Principal Investigator
Safinamide in Idiopathic Parkinson's disease (IPD) With Motor Fluctuations, as Add-on to Levodopa. A phase III, double-blind, placebo-controlled, randomised trial to determine the efficacy and safety

EMD Serono, Inc.
28850
Principal Investigator
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson’s disease Patients

IMPAX Laboratories, Inc.
IPX066-B08-05
Additional Investigator
A placebo-controlled study to evaluate the safety and efficacy of IPX066 in subjects with Parkinson’s disease

Allergan, Inc.
MedAff BTX-0718/CD-PROBE
Additional Investigator
Cervical Dystonia Patient Registry for Observation of BOTOX Efficacy

Cynapsus Pharmaceuticals
CTH 300
Site Sub-Investigator
A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to examine the efficacy, safety, and tolerability of APL-13027 in Levodopa Responsive Parkinson’s Disease Patients Complicated by Motor Fluctuations (OFF Episodes) (also open-label extension study CTH 301)

AbbVie
M15-562
Site Sub-Investigator
A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Study to Assess Safety, Pharmacokinetic, and Preliminary Efficacy of ABBV-8E12 in Progressive Supranuclear Palsy

IMPAX Laboratories, Inc.
IPX066-B08-11
Additional Investigator
A study to compare the pharmacokinetics and pharmacodynamics of IPX066 to standard carbidopa-levodopa

IMPAX Laboratories, Inc.
IPX066-B09-02
Additional Investigator
A Study to Evaluate the Safety and Efficacy of IPX066 in Advanced Parkinson's Disease in the treatment of advanced PD subjects in comparison to IR CD-LD

Movement Disorders Database
Maintaining ongoing database of patients seen at JBVA for analysis.

Main Section
- Colleges
- For Professionals
- For Students
- Resources
  - Alumni
  - Get Directions
  - News & Events
  - Cookie Settings
(312) 942-7100
Rush University
600 S. Paulina St.
Chicago, Illinois 60612

Contact Us

Accessibility, Privacy & Harassment Policies

© 2025 Rush University